RIBAS MAYNOU JOSEP

On 1 de March de 2016, Ribas Maynou Josep was named and registered in the Companies Registry as Apoderado solidario/mancomunado.

Their activity as INSTITUTO EUROPEO DEL DOLOR ARTICULAR SL in the company Apoderado solidario/mancomunado ended in March de 2016.

This Barcelona-based company operates in la prestacion,a hospitales y centros de salud en general,de servicios de gestion integral de las distintas areas medicas externalizadas por dichos centros y hospitalesasesoramiento en materia sanitaria,etc... sector.

Their activity as BIOIBERICA SA in the company Desconocido ended in December de 2023.

Ribas Maynou Josep is currently the Apoderado solidario/mancomunado at this company.

On December de 2017 they ended their participation as Apoderado solidario/mancomunado in this company.

They left their position of Desconocido of this company in December de 2017.

Ribas Maynou Josep left the position of Apoderado in April de 2016.

On 8 de August de 2014 their appointment as Apoderado mancomunado of this company was included in the Companies Register.

From 6 de August de 2013, Ribas Maynou Josep has held the position of Apoderado mancomunado.

With registered office in Barcelona, it undertakes its business in the manufacture of basic pharmaceutical products... sector.

They participated as Desconocido of this company but ended their activity on January de 2023.

On 11 de December de 2017 their appointment was registered as Apoderado solidario/mancomunado of this company .

On 2 de March de 2016 their appointment as Apoderado solidario/mancomunado was published.

Ribas Maynou Josep left the position of Apoderado solidario/mancomunado in March de 2016.

They ended their position as Apoderado of this company on 16 de October de 2015.

From 31 de July de 2014, Ribas Maynou Josep has held the position of Apoderado mancomunado.

On August de 2013 they were appointed as Apoderado mancomunado of this company.

With registered office in Barcelona, it undertakes its business in the manufacture of basic pharmaceutical products... sector.